Summary
The theme for this year’s DIA 2017 Annual Meeting was “Driving Insights to Action.” DIA hosted more than 7,000 professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries around the globe. Given the broad multidisciplinary nature of the attendees, PRA Health Sciences wanted to gather actionable insights from this heterogeneous group. We wanted to know their thoughts on the state of innovation and technology in the life-sciences industry and what would have the greatest impact on this industry in the near term.
Register to download
PRA Insights Report 2017
You may also be interested in:
Fact Sheet
LC-MS/MS Support for Studies with Large Molecules
PRA’s Bioanalytical Laboratories provide LC-MS/MS services to support clients’ studies with biological and small molecules. The information details…
Newsletter
Biosimilars Newsletter Volume 4, October 2014
Welcome to the fourth edition of Biosimilars Newsletter, a quarterly publication dedicated to keeping you updated on current biosimilars news,…
page
Therapeutic Expertise
A core aspect of the drug development landscape has been and always will be an intimate expertise in therapeutic areas. Our experts will partner with…